Side effects across medicines
Medicines whose labels list muscle pain
624 medicines have an FDA label that names muscle pain (myalgia) in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of muscle pain name atorvastatin (9,961), simvastatin (8,443) and omeprazole (5,878), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list muscle pain?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 150 of the 624 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of muscle pain |
|---|---|---|
| Furosemide | precautions | 3,962 |
| Ciprofloxacin | warnings and precautions (intravenous label) | 2,891 |
| Hydrochlorothiazide | precautions | 2,206 |
| Levofloxacin | warnings and precautions (intravenous label) | 1,220 |
| Moxifloxacin | warnings and precautions (intravenous label) | 269 |
| Chlorthalidone | precautions | 171 |
| Hydrochlorothiazide and lisinopril | precautions | 145 |
| Ibandronate | warnings and precautions (intravenous label) | 142 |
| Ofloxacin | warnings (oral label) | 140 |
| Metolazone | precautions | 134 |
| Hydrochlorothiazide and triamterene | precautions | 102 |
| Amiloride and hydrochlorothiazide | precautions | none in the top 1,000 |
| Atenolol and chlorthalidone | precautions | none in the top 1,000 |
| Avutometinib and defactinib | warnings and precautions | none in the top 1,000 |
| Bisoprolol and hydrochlorothiazide | precautions | none in the top 1,000 |
| Caffeine and ergotamine | precautions | none in the top 1,000 |
| Captopril and hydrochlorothiazide | precautions | none in the top 1,000 |
| Chlorothiazide | precautions | none in the top 1,000 |
| Dihydroergotamine | warnings (intramuscular/ | none in the top 1,000 |
| Enalapril and hydrochlorothiazide | precautions | none in the top 1,000 |
| Entacapone | precautions | none in the top 1,000 |
| Ergotamine | precautions | none in the top 1,000 |
| Glipizide and metformin | precautions | none in the top 1,000 |
| Mesna | warnings and precautions (oral label) | none in the top 1,000 |
| Nafarelin | precautions | none in the top 1,000 |
| Pamidronate | precautions | none in the top 1,000 |
| Procainamide | precautions | none in the top 1,000 |
| Taletrectinib adipate | warnings and precautions | none in the top 1,000 |
| Atorvastatin | adverse reactions | 9,961 |
| Simvastatin | adverse reactions | 8,443 |
| Omeprazole | adverse reactions | 5,878 |
| Evolocumab | adverse reactions | 5,419 |
| Ezetimibe | adverse reactions | 4,492 |
| Lisinopril | adverse reactions | 4,000 |
| Dupilumab | adverse reactions | 3,958 |
| Amlodipine | adverse reactions | 3,900 |
| Methotrexate | adverse reactions | 3,692 |
| Rosuvastatin | adverse reactions | 3,423 |
| Pregabalin | adverse reactions | 3,419 |
| Clopidogrel | adverse reactions | 2,964 |
| Pantoprazole | adverse reactions | 2,955 |
| Esomeprazole | adverse reactions (intravenous label) | 2,767 |
| Losartan | adverse reactions | 2,516 |
| Tadalafil | adverse reactions | 2,155 |
| Alendronate | adverse reactions | 2,103 |
| Ramipril | adverse reactions | 2,067 |
| Selexipag | adverse reactions | 1,981 |
| Clonazepam | adverse reactions | 1,966 |
| Zoledronic acid | adverse reactions | 1,866 |
| Infliximab | adverse reactions | 1,862 |
| Escitalopram | adverse reactions | 1,821 |
| Interferon beta 1a | adverse reactions | 1,814 |
| Montelukast | adverse reactions | 1,784 |
| Allopurinol | adverse reactions | 1,747 |
| Omalizumab | adverse reactions | 1,735 |
| Treprostinil | adverse reactions | 1,728 |
| Alirocumab | adverse reactions | 1,683 |
| Fluticasone | adverse reactions (respiratory (inhalation) label) | 1,664 |
| Sildenafil | adverse reactions | 1,660 |
| Zolpidem | adverse reactions | 1,659 |
| Lenalidomide | adverse reactions | 1,636 |
| Citalopram | adverse reactions | 1,575 |
| Ribavirin | adverse reactions | 1,372 |
| Letrozole | adverse reactions | 1,348 |
| Rituximab | adverse reactions | 1,289 |
| Peginterferon alfa 2a | adverse reactions | 1,251 |
| Oxycodone | adverse reactions | 1,240 |
| Bupropion | adverse reactions | 1,222 |
| Mirtazapine | adverse reactions | 1,185 |
| Anastrozole | adverse reactions | 1,081 |
| Pembrolizumab | adverse reactions | 1,017 |
| Lamotrigine | adverse reactions | 1,015 |
| Baclofen | adverse reactions | 988 |
| Tiotropium | adverse reactions | 988 |
| Cyclosporine | adverse reactions | 973 |
| Azathioprine | adverse reactions | 962 |
| Trastuzumab | adverse reactions | 929 |
| Aripiprazole | adverse reactions | 924 |
| Cyclophosphamide | adverse reactions | 909 |
| Natalizumab | adverse reactions | 909 |
| Ofatumumab | adverse reactions | 899 |
| Fenofibrate | adverse reactions | 896 |
| Sitagliptin | adverse reactions | 868 |
| Ranitidine | adverse reactions | 866 |
| Paclitaxel | adverse reactions | 862 |
| Mycophenolate mofetil | adverse reactions | 860 |
| Isotretinoin | adverse reactions | 850 |
| Sulfamethoxazole and trimethoprim | adverse reactions | 850 |
| Pitavastatin | adverse reactions | 845 |
| Risedronate | adverse reactions | 842 |
| Nilotinib | adverse reactions | 831 |
| Acyclovir | adverse reactions | 823 |
| Docetaxel | adverse reactions | 809 |
| Relugolix | adverse reactions | 802 |
| Duloxetine | adverse reactions | 800 |
| Cyclobenzaprine | adverse reactions | 775 |
| Topiramate | adverse reactions | 773 |
| Insulin lispro | adverse reactions | 760 |
| Nivolumab | adverse reactions | 712 |
| Fluvastatin | adverse reactions | 684 |
| Ezetimibe and simvastatin | adverse reactions | 675 |
| Tacrolimus | adverse reactions | 662 |
| Pravastatin | adverse reactions | 656 |
| Diltiazem | adverse reactions | 652 |
| Budesonide | adverse reactions | 640 |
| Leuprolide | adverse reactions | 637 |
| Bevacizumab | adverse reactions | 636 |
| Varenicline | adverse reactions | 627 |
| Enalapril | adverse reactions | 615 |
| Exemestane | adverse reactions | 615 |
| Levetiracetam | adverse reactions | 611 |
| Fluconazole | adverse reactions | 610 |
| Mepolizumab | adverse reactions | 569 |
| Ustekinumab | adverse reactions | 566 |
| Estrogens conjugated | adverse reactions | 559 |
| Lovastatin | adverse reactions | 559 |
| Fingolimod | adverse reactions | 546 |
| Eculizumab | adverse reactions | 529 |
| Sumatriptan | adverse reactions (subcutaneous label) | 529 |
| Paroxetine | adverse reactions | 524 |
| Telmisartan | adverse reactions | 521 |
| Clarithromycin | adverse reactions | 508 |
| Colchicine | adverse reactions | 506 |
| Sofosbuvir | adverse reactions | 488 |
| Capecitabine | adverse reactions | 472 |
| Imatinib | adverse reactions | 469 |
| Pioglitazone | adverse reactions | 463 |
| Lenvatinib | adverse reactions | 458 |
| Human immunoglobulin g | adverse reactions | 456 |
| Botulinum toxin type a | adverse reactions | 454 |
| Risperidone | adverse reactions | 453 |
| Dexlansoprazole | adverse reactions | 449 |
| Buprenorphine | adverse reactions (transdermal label) | 437 |
| Gemfibrozil | adverse reactions | 421 |
| Tramadol | adverse reactions | 420 |
| Nifedipine | adverse reactions | 419 |
| Fulvestrant | adverse reactions | 415 |
| Cabozantinib | adverse reactions | 403 |
| Rabeprazole | adverse reactions | 398 |
| Pertuzumab | adverse reactions | 393 |
| Upadacitinib | adverse reactions | 384 |
| Naltrexone | adverse reactions | 382 |
| Mycophenolic acid | adverse reactions | 368 |
| Methylphenidate | adverse reactions | 365 |
| Epoprostenol | adverse reactions | 357 |
| Vemurafenib | adverse reactions | 355 |
| Ritonavir | adverse reactions | 337 |
| Isosorbide mononitrate | adverse reactions | 332 |
| Glyburide | adverse reactions | 331 |
| Niacin | adverse reactions | 328 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most muscle pain reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Myalgia”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch